友情提示：以下期刊信息可能会有更新，仅供参考，请在投稿前自行登录期刊官网仔细核实。
期刊名
BIOMEDICAL CHROMATOGRAPHY
BIOMED CHROMATOGR
ISSN / eISSN
0269-3879 / 1099-0801
目标和范围
Biomedical Chromatography is devoted to the publication of original papers on the applications of chromatography and allied techniques in the biological and medical sciences. Research papers and review articles cover the methods and techniques relevant to the separation, identification and determination of substances in biochemistry, biotechnology, molecular biology, cell biology, clinical chemistry, pharmacology and related disciplines. These include the analysis of body fluids, cells and tissues, purification of biologically important compounds, pharmaco-kinetics and sequencing methods using HPLC, GC, HPLC-MS, TLC, paper chromatography, affinity chromatography, gel filtration, electrophoresis and related techniques.
研究方向
生化研究方法
生化与分子生物学
分析化学
CiteScore
3.60
查看趋势图
CiteScore 学科排名
| 类别 | 分区 | 排名 |
|---|---|---|
| Chemistry - Analytical Chemistry | Q3 | #81/156 |
| Chemistry - Pharmacology | Q3 | #187/313 |
| Chemistry - Drug Discovery | Q3 | #99/157 |
| Chemistry - Clinical Biochemistry | Q3 | #76/117 |
| Chemistry - Biochemistry | Q3 | #295/438 |
| Chemistry - Molecular Biology | Q3 | #300/410 |
Web of Science 核心收藏夹
| Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
|---|---|
| Indexed | - |
| 类别 (Journal Citation Reports 2024) | 分区 |
|---|---|
| BIOCHEMICAL RESEARCH METHODS | Q4 |
| BIOCHEMISTRY & MOLECULAR BIOLOGY | Q4 |
| CHEMISTRY, ANALYTICAL | Q3 |
| PHARMACOLOGY & PHARMACY | Q3 |
H-index
58
出版国家或地区
ENGLAND
出版商
John Wiley and Sons Ltd
出版周期
Monthly
出版年份
1986
年文章数
235
Open Access
NO
通讯方式
JOHN WILEY & SONS LTD, THE ATRIUM, SOUTHERN GATE, CHICHESTER, ENGLAND, W SUSSEX, PO19 8SQ
认证评论
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now